Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 48 Neoplasms 43 Depression 31 Fatigue 30 Prostatic Neoplasms 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 20 Lymphoma, Follicular 18 Lymphoma, Large B-Cell, Diffuse 17 Multiple Myeloma 16 Carcinoma, Non-Small-Cell Lung 16 Lymphoma, Non-Hodgkin 15 Lung Neoplasms 15 Leukemia, Lymphocytic, Chronic, B-Cell 15 Lymphoma, Mantle-Cell 14 Leukemia, Myeloid, Acute 14 Hodgkin Disease 14 Colorectal Neoplasms 14 Burkitt Lymphoma 14 Anxiety Disorders 14 Pain 13 Lymphoma, B-Cell, Marginal Zone 13 Lymphoma, Large-Cell, Immunoblastic 12 Lymphoma 11 Leukemia, Myeloid, Chronic-Phase 11 Head and Neck Neoplasms 11 Blast Crisis 11 Lymphoma, T-Cell, Cutaneous 10 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 10 Leukemia, Myeloid, Accelerated Phase 10 Leukemia, Hairy Cell 10

Interventions

exemestane 1 Vorinostat 1 Therapeutics 1 Surgical Procedures, Operative 1 Mifepristone 1 Letrozole 1 Aromatase Inhibitors 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Endometrial Stromal Tumors × Therapeutics × Clear all

NCT02829437 2026-01-02

EST

Italian Sarcoma Group

Endometrial Stromal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡